APP and Alzheimer disease: Recently, in the AD mouse model (mutant human transgenes of APP and Presenilin-1 (PS1)), the mitochondrial biogenesis markers (PGC-1α, NRF1 and 2, and mTFA) were also declined, particularly in the hippocampus region [90].